ARCHIVES

More money would speed progress, NCI says, but backs off previous commitment to meet 2015 goal by 2010.

This article is from The Cancer Letter archive.

Vol. 31 No. 30 | July 29, 2005

Download PDF Visit The Full Archive

Related Articles

DCPC Board Approves Concepts for $28.5 Million Polyp Trial, Other Nutrition Related Studies

May 19, 1989

American Health Fdn. Honors NCI On Act’s 20th Anniversary

December 13, 1991

Swedish Education Says Nursing Education Should Emphasize Decision Making

December 4, 1987

Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says.

May 7, 2004

No Benefit To Shark Cartilage As Treatment, Large Trial Finds

July 27, 2007

NCI Director and Acting FDA Commissioner Andrew von Eschenbach Endorses Rep. E. Clay Shaw In Tour of Florida Congressman’s District. Von Eschenbach Praises Shaw’s “Leadership” In Seeking Funding For Research, Support of 2015 Goal.

February 3, 2006